ADVANCE (2008) — Trial Summary
ADVANCE (2008): Randomized factorial trial in adults with type 2 diabetes comparing intensive glucose control (target HbA1c <6.5%) versus standard glucose control, with a separate blood-pressure–lowering factorial (NCT00145925). Primary outcomes: major macrovascular and major microvascular events (i
References
- ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560-2572.